Andrew York

Company: Maryland Prescription Drug Affordability Board

Job title: Executive Director

Seminars:

Uncovering the Benefits of State Wide Prescription Drug Affordability Board’s to Reduce High Costs Associated with GLP-1s for Diabetes 12:30 pm

Detailing the specific powers and mandate of the Maryland Prescription Drug Affordability Board (PDAB), highlighting their recent or ongoing focus on the cost of GLP-1 receptor agonists, given their significant utilization and budget impact Explaining the processes, the Maryland PDAB employs to review the cost of GLP-1s, including data analysis, stakeholder engagement, and the potential…Read more

day: Conference Day One

Panel Discussion: Discussing the Potential Impact of GLP-1 Coverage on State & Federal Budgets & Healthcare Systems 2:00 pm

Highlighting the prevalence of diabetes and obesity in lower income families that rely on public healthcare systems Discussing the potential for AOMs to improve public health outcomes and reduce the long-term costs of treatment associated with the end-stage results of obesity such as MASH and heart disease Understanding the direct cost of GLP-1 coverage per…Read more

day: Conference Day One

Panel Discussion: Understanding Targeted Coverage for Obesity Drugs by Navigating Comorbidities, Payers & Pharma Acquisitions 3:30 pm

Discussion on the necessity of specific comorbidities such as, prediabetes, osteoarthritis, sleep apnea, heart failure, for obesity drug coverage Exploring the challenges payers face in adapting coverage policies for obesity drugs, including rapid policy changesRead more

day: Conference Day Two